Cardiovascular risk during hormonal treatment in patients with prostate cancer.
about
Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapyMetabolic effects of androgen deprivation therapyThe role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysisThe relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancerChanges in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study.
P2860
Cardiovascular risk during hormonal treatment in patients with prostate cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cardiovascular risk during hormonal treatment in patients with prostate cancer.
@ast
Cardiovascular risk during hormonal treatment in patients with prostate cancer.
@en
Cardiovascular risk during hormonal treatment in patients with prostate cancer.
@nl
type
label
Cardiovascular risk during hormonal treatment in patients with prostate cancer.
@ast
Cardiovascular risk during hormonal treatment in patients with prostate cancer.
@en
Cardiovascular risk during hormonal treatment in patients with prostate cancer.
@nl
prefLabel
Cardiovascular risk during hormonal treatment in patients with prostate cancer.
@ast
Cardiovascular risk during hormonal treatment in patients with prostate cancer.
@en
Cardiovascular risk during hormonal treatment in patients with prostate cancer.
@nl
P2860
P356
P1476
Cardiovascular risk during hormonal treatment in patients with prostate cancer.
@en
P2093
Bertrand Tombal
Hein Van Poppel
P2860
P356
10.2147/CMR.S16893
P407
P577
2011-03-02T00:00:00Z